Remarkably, studies carried out using in vivo and in vitro models of retinal damage showed overexpression of MT1 and MT2 isoforms, suggesting that their up-regulation may be protective against acute retinal insults,74–76 which may explain the higher levels of MT1A observed in the AMD patients of this work. The gene discussed is MT1A; the disease is age-related macular degeneration.